Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Association with morphology and resistance to conventional chemotherapy

Cancer Genetics and Cytogenetics

Volumn 90, Issue 2, 1996, Pages 118-124

  Cano, Isabel ^a,b   Martinez, J ^a   Quevedo, E ^a   Pinilla, J ^a   Martin Recio, A ^a   Rodriguez, A ^a   Castaneda A ^a   Lopez R ^a   Perez Pino T ^a   Hernandez Navarro F ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RESISTANCE; CHROMOSOME 12; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HEPATOMEGALY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SPLENOMEGALY; TRISOMY;

EID: 0030248425     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00063-5     Document Type: Article

References (42)

1. Dörmer P, Theml H, Lau B (1983): Chronic lymphocytic leukemia: A proliferative or an accumulative disorder? Leuk Res 7:1-10.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. The French-American-British (FAB) Cooperative Group (1988): Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol 42:567-584.
3. Gobbi M, Caligaris-Cappio F, Janossy G (1983): Normal equivalent of B-cell malignancies: Analysis with monoclonal antibodies. Br J Haematol 54:393-403.
4. Gahrton G, Robert KH, Friberg K, Zech L, Bird AG (1980): Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell mitogen stimulation. Blood 56:640-647.
5. Juliusson G, Oscier DG, Fitchett M, Ross F, Phil D, Stockdill G, Mackie MJ, Parker AC, Castoldi CL, Cuneo A, Knuutila S, Elonen E, Gahrton G (1990): Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323:720-724.
6. Peterson LC, Lindquist L, Church S, Kay NE (1992): Frequent clonal abnormalities of chromosome band 13q14 in B-cell chronic lymphocytic leukemia: Multiple clones, subclones and nonclonal alterations in 82 midwestern patients. Genes Chrom Cancer 4:273-280.
7. Anastasi J, Le Bau MM, Vardiman J, Westbrook CA (1992): Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: A simple and sensitive method. Blood 79:1796-1801.
8. Que TH, Garcia-Marco J, Ellis J, Matutes E, Babapulle B, Boyle S, Catovsky D (1993): Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Analysis by stage, immunophenotype and morphology. Blood 82:571-575.
9. Stilgenbauer S, Döhner H, Bulgay-Mörschel M, Weitz S, Bentz M, Lichter P (1993): High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood 81:2118-2124.
10. Cremer T, Landegent J, Brückner A, Scholl HP, Schardin M, Hager HD, Deville P, van der Ploeg M (1986): Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization techniques: Diagnosis of trisomy 18 with probe L1.84. Hum Genet 74:346-352.
11. Bentz M, Döhner H, Cabot G, Lichter P (1994): Fluorescence in situ hybridization in leukemias: The FISH are spawning! Leukemia 8:1447-1452.
12. Juliusson G, Oscier D, Gahrton G for the IWCCLL (1991): Cytogenetic findings and survival in B lymphocytic leukemia. Second international compilation of data on 662 patients. Leukemia Lymphoma 5 (suppl):21-25.
13. Criel A, Wlodarska I, Meeus P, Stul M, Louwagie A, van Hoof A, Hidajat M, Mecucci C, Van Den Berghe H (1994): Trisomy 12 is uncommon in typical chronic lymphocytic leukemias. Br J Haematol 87:523-528.
14. Matutes E, Oscier D, Garcia-Marco J, Ellis J, Chapman R, Gillingham R, Hamblin T, Catovsky D (1994): Trisomy 12 defines a subgroup of CLL with a distinct morphology. Blood 84, (suppl): 2611.
15. Liu Y, Szekely L, Grandér D, Söderhäll S, Juliusson G, Gahrton G, Linder S, Einhorn S. Chronic lymphocytic leukemia cells with allelic deletions at 13g14 commonly have one intact RB1 gene. Evidence for a role of an adjacent locus. Proc Natl Acad Sci USA 1993; 90:8697-8701.
16. Hawthorn LA, Chapman R, Oscier D, Cowell JK (1993): The consistent 13q14 translocation breakpoint seen in chronic B-cell leukemia involves deletion of the D13S25 locus which lies distal to the retinoblastoma predisposition gene. Oncogene 8:1415-1419.
17. Brown A, Ross F, Dunne M, Steel CM, Weir-Thompson EM. Evidence for a new tumor suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nat Genet 1993; 3:67-72.
18. Harris CC, Hollstein M (1993): Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318-1327.
19. Levine A, Momand J, Finlay C (1991): The p53 tumor suppressor gene. Nature 351:453-456.
20. Ichikawa A, Hotta T, Takagi N, Tsushita K, Kinoshita T, Nagai H, Murakimi Y, Hayashi K, Saito H (1992): Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood 79:2701-2707.
21. Imamura J, Miyoshi Y, Koeffler HP (1994): p53 in hematologic malignancies. Blood 8:2412-2421.
22. Foti A, Ahuja HG, Allen SL, Koduru P, Schuster MW, Schulman P, Bar-Eli M, Cline MJ (1991): Correlations between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis. Blood 77:2441-2455.
23. Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, Raffeid M (1993): p53 mutation is associated with progression in follicular lymphomas. Blood 82;1994-2004.
24. Wattel E, Preudhomme C, Hecquet B, Varumbeke M, Quesnel B, Dervite I, Morel P, Fenaux P (1994): p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 84;3148-3157.
25. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R (1991): p53 mutation in human lymphoid malignancies association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413-5417.
26. Fenaux P, Preudhomme C, Lai JL, Quiquandon I, Jonveaux P, Vanrumbeke M, Sartiaux C, Morel P, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert JP (1992): Mutations of the p53 in B-cell chronic lymphocytic leukemia: A report on 39 cases with cytogenetic analysis. Leukemia 6:42-46.
27. EI Rouby S, Thomas A, Costin D, Rosenberg CR, Potmesil M, Silber R, Newcomb EW (1993): p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood 82;3452-3459.
28. Döhner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, Diehl D, Schlenk R, Coy J, Volkman M, Galle PR, Poustka A, Hunsein W, Lichter P (1995): p53 deletion predicts poor survival and non-response to therapy with purine analogs in chronic B-cells leukemias. Blood 85;1580-1589.
29. Rai K, Sawitsky A, Cronkite E, Chanana AB, Leey RN, Pasternack BS (1975): Clinical staging of chronic lymphocytic leukemia. Blood 46:219-234.
30. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vauguier G, Potron G, Colona P, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Montconduit M (1981): A new prognostic classification of chronic lymphocytic leukemia derived from multivariate analysis. Cancer 48:198-206.
31. Anastasi J, Le Beau MM, Vardiman JW, Wesbrook CA (1990): Detection of numerical chromosomal abnormalities in neoplastic hematopoietic cells by in situ hybridization with a chromosome-specific probe. Am J Path 136:131-139.
32. Döhner H, Pohl S, Bulgay-Mörschel M, Stilgenbauer S, Bentz M, Lichter P (1993): Trisomy 12 in chronic lymphoid leukemias, a metaphase and interphase cytogenetic analysis. Leukemia 7:516-520.
33. Losada AP, Wessman M, Tiainen M, Hopman A, Willard HF, Sole F, Caballiń MR, Woessner S, Knuutila S (1991): Trisomy 12 in chronic lymphocytic leukemia: An interphase cytogenetic study. Blood 78:775-779.
34. Qumsiyeh MB, Tharapel SA (1992): Interphase detection of trisomy 12 in B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization. Leukemia 6:602-605.
35. Cuneo A, Wlodarska I, Aly MS, Piva N, Carli G, Faglioli F, Tallarico A, Pazzi I, Ferrari L, Cassiman JJ, van den Berghe H, Castoldi GL (1992): Non-radioactive in situ hybridization for the detection and monitoring of trisomy 12 in B-cell chronic lymphocytic leukemia. Br J Haematol 81:192-196.
36. Melo JV, Catovsky D, Gregory WM, Galton DA (1987): The relationship between chronic lymphocytic leukemia and prolymphocytic leukemia IV. Analysis of survival and prognostic features. Br J Haematol 65:23-29.
37. Vallespí T, Monserrat E, Sanz MA (1991): Chronic lymphocytic leukemia: Prognostic value of lymphocytes morphological subtypes. A multivariate survival analysis in 146 patients. Br J Haematol 77:478-485.
38. Oscier DG, Copplestone A, Chapman R, Gillingham R, Hamblin T, Catovsky D, Matutes E (1994): Atypical lymphocyte morphology and abnormal karyotype predict disease regression in stage A and AO chronic lymphocytic leukemia. Blood 84 (suppl):1972.
39. Garcia-Marco J, Matutes E, Morilla R, Ellis D, Fantes J, Catovsky D, Price CM (1994): Trisomy 12 in B-cell chronic lymphocytic leukemia: Assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in situ hybridization. Br J Haematol 87:44-50.
40. García-Marco J, Pride MC, Ellis J, Morilla R, Lens D, Matutes E, Oscier D, Catovsky D (1994): "In vitro" proliferation in chronic lymphocytic leukemia. An interphase cytogenetic analysis of clonal growth after mitogen stimulation. Blood 87(suppl):1795.
41. Kubic VL, Hoyt KJ, Peterson LC (1992): Interphase fluorescent in situ hybridization for trisomy 12 substantiates the utility of mitogens in the cytogenetic analysis of low grade lymphoproliferative processes. Blood 80 (Suppl):773.
42. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JKV, Hamilton S, Volgestein B (1990): p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50:1717-1722.